ScanSource’s fiscal Q4 revenue rose ~17% YoY to $953.1M, beating the Street by ~$151M, and non-GAAP EPS of $1.46 topped consensus by $0.32. The company is also set to buy MicroAge for $220.5M (expected close by Sept. 30), guiding the deal to be accretive to sales, margins, adjusted earnings and free cash flow within year one. For fiscal 2027, ScanSource expects 6%–10% sales growth (ex-MicroAge), adjusted EBITDA of $158M–$165M, and adjusted free cash flow of at least $85M, sending the stock up as much as 28.4% on the day.
This reads less like a one-quarter beat and more like a management team buying itself optionality through consolidation. In a low-margin distribution model, scale and breadth matter more than headline growth: if the MicroAge integration works, the real upside is not just incremental revenue but better vendor leverage, cross-sell density, and a lower cost-to-serve that can compound for several quarters. The competitive pressure lands on smaller resellers and channel partners first, while larger public peers such as SNX and CDW may face higher expectations that they can also accelerate through tuck-in deals.
The caution flag is quality of earnings. When EBITDA is expected to rise but free cash flow is guided lower, the market should ask whether working capital, integration costs, or acquisition financing are absorbing the apparent operating strength. That makes this more of a 1-3 month estimate-revision story than a clean multi-year rerating today; if inventory days or receivables normalize poorly, the post-earnings enthusiasm can fade fast. Falsifiers: any delay to the deal close, a downward revision to FY27 EBITDA/FCF, or evidence that the acquired revenue comes with materially weaker margin mix than implied.
Consensus may be underweighting how much acquisition-driven growth can matter for a subscale distributor, but it may also be overestimating how much of the beat is repeatable. The stock can work tactically if the market starts capitalizing a higher organic growth/run-rate plus deal synergies, but the best risk/reward is likely after the gap consolidates rather than chasing the opening move. If the next print shows conversion of the guidance into cash and no deterioration in working-capital turns, the re-rating can extend; if not, this becomes a classic sell-the-news channel name.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment
